1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804

Value Stock, Under Radar
Download real time

1082.45 24.45 (2.31%)

New 52W Low in past week

1.6M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
13S
9W
6O
4T
62,868.9

Market Cap

High in industry
18

PE TTM

Below industry Median
0.7

PEG TTM

PEG TTM is less than 1
2

Price to Book

Below industry Median
0.8

Beta 1Year

Very Low volatility
US FDA Approval
Aurobindo Pharma gets US FDA approval to produce Rivaroxaban tablets with a market size of $8.5 bn See details

Aurobindo Pharma Ltd. - AUROPHARMA - stock price prediction, stock forecast, target price, analyst ratings from 28 analysts

Aurobindo Pharma Ltd. has a share price target of Rs 1477, revenue growth forecast of 8.8%, and profit growth estimate of 16.0% for FY25, based on top 28 analyst calls.

Forecaster Screeners